Standout Papers
- The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (2006)
- Immune Activation in Patients With Irritable Bowel Syndrome (2007)
- Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting (2019)
- Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (2021)
Immediate Impact
9 by Nobel laureates 34 from Science/Nature 61 standout
Citing Papers
GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Works of Alexander Röth being referenced
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial
2021
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Alexander Röth | 2703 | 1837 | 1430 | 147 | 5.3k | |
| Otto Götze | 4131 | 1432 | 917 | 133 | 6.4k | |
| Élie Haddad | 3127 | 1846 | 591 | 174 | 6.7k | |
| Leendert A. Trouw | 4613 | 1199 | 540 | 213 | 9.5k | |
| K Whaley | 2104 | 884 | 726 | 196 | 4.6k | |
| Allan Wiik | 2171 | 547 | 1681 | 172 | 9.7k | |
| C M Lockwood | 2085 | 739 | 1445 | 182 | 8.4k | |
| Gerd‐Rüdiger Burmester | 3096 | 1367 | 1057 | 153 | 8.5k | |
| Claire L. Harris | 3791 | 1235 | 368 | 124 | 5.4k | |
| Thomas J. Lawley | 1831 | 801 | 917 | 100 | 7.6k | |
| Francesco Liotta | 5652 | 634 | 1685 | 97 | 10.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...